<DOC>
	<DOCNO>NCT00535483</DOCNO>
	<brief_summary>The EU fund project CLINICIP ( Closed Loop Insulin Infusion Critically Ill Patients ) aim develop low-risk monitoring control device allow maintain metabolic control intensive care unit . A system develop comprise three subsystem : body interface delivery biofluids , biosensors determination glucose concentration biofluids adaptive control algorithm generate advice thus represent decision support system respect insulin infusion rate establish glycaemic control critically ill patient . Within close loop system , intensified insulin treatment make use calculation lead external regulation glucose . It aim study evaluate feasibility establish glycaemic control type 1 diabetic subject period 30 hour manually combine three - previously test - subsystem ( ABS System , extracorporeal online glucose sensor laptop-based computer algorithm ) .</brief_summary>
	<brief_title>Closed Loop Insulin Therapy Type 1 Diabetics Based Blood Microdialysis , Online Sensors eMPC Algorithm</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Signed informed consent obtain trialrelated activity Age analysable subject range 18 65 year Type 1 diabetes ( Treatment multiple daily injection 12 month ) Severe acute and/or chronic disease Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation Taking vasoactive substance anticoagulation medication . Diseases skin could interfere application catheter . Pregnancy breastfeed Bleeding disorder Known heparin allergy heparin intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>blood microdialysis</keyword>
	<keyword>glucose monitoring</keyword>
	<keyword>glucose control</keyword>
	<keyword>automate blood sample</keyword>
	<keyword>online-sensor</keyword>
	<keyword>algorithm</keyword>
	<keyword>type 1 diabetes</keyword>
</DOC>